The nations first upper payment limit, set to take effect in January 2027, has been temporarily paused. Chief Judge Daniel Domenico said Amgen would face significant and irreparable harm because of the price cap, and found that federal patent law likely preempted a state price cap, reported Reuters.
A Call to Action: Restoring and Strengthening America’s Patient Safety System presents a two pillar system for regulators and lawmakers to preserve the FDAs gold standard.
ADAP Advocacy and the Partnership for Safe Medicines (PSM) issued the following joint statement as a warning to pharmacists that all discounted HIV products bought from online, pharmacy-to-pharmacy (P2P) marketplaces fit the definition of suspect product under U.S. Food and Drug Administration (FDA) guidelines and the Drug Supply Chain Security Act.
The Partnership for Safe Medicines and ADAP Advocacy are warning that discounted HIV products bought from online, pharmacy-to-pharmacy (P2P) marketplaces qualify as suspicious products under U.S. Food and Drug Administration guidelines and the Drug Supply Chain Security Act. Given the risks, we believe that it isn’t safe or cost-effective to purchase HIV products from these platforms.
Read our roadmap to uphold the gold standard system that protects Americans from untested and unsafe medicines.
AFPs, which often force patients to source medicines overseas, may present access concerns according to a new study.
Our podcast covers the latest in pharma crime and medicine safety.
Like your information on video? Subscribe to our YouTube playlist!
How can we secure patient safety in the compounded drug era?
What are research-grade drugs? They're not safe medicine.
Click the images below to see more recent videos.




